World Drug Discovery Contract Research Markets: Profiles of the Top 50 Global Outsourcers


USD 3,950.00

* Required Fields

USD 3,950.00


Be the first to review this product

In the recent past, the global pharma industry has been under pressure to bring out blockbuster drugs to strengthen its drying pipelines, as well as overcome loss of sales to generics due to best-selling drugs going off patent. Managing the drug discovery process and technologies has become one of the top challenges faced by the global pharma industry in the recent past; herein lies the opportunity for a spate of companies focusing on contract research in drug discovery. This report presents the profiles of top 50 drug discovery outsourcers. The segments include outsourcing of research by big and mid-sized pharma and biotech companies.

Table of Contents

World Drug Discovery Contract Research Markets, Executive SummaryExecutive SummaryExecutive SummaryWorld Drug Discovery Contract Research Markets, OverviewIntroductionOverviewScope of StudyChallengesChallengesEstablishing CredibilityDeveloping Strategic Fit between Outsourcers and CROMoving up the Value ChainDriversMarket DriversGlobal R&D ProductivityCost Advantages Leading to Growth in OutsourcingIncrease in Time and Labor Intensive R&D ProcessesRestraintsMarket RestraintsLack of Strong IPR ProtectionLack of Domain Expertise Limiting CR OpportunitiesUnavailability of World-Class Infrastructure and ManpowerWorld Drug Discovery Contract Research Markets, Top Drug Discovery Research Outsourcers' ProfilesBig PharmaAbbott LaboratoriesAstraZeneca PLCAventis PharmaBayer AGBristol-Myers Squibb CompanyBoehringer Ingelheim GmbHEli Lilly & CoGlaxoSmithKline PlcJohnson & JohnsonMerck & Co IncNovartis AGNovo Nordisk S/APfizer IncF. Hoffman-La Roche LtdSchering AGSchering Plough CorporationMid-Size PharmaDaiichi Pharmaceutical Co. LtdEisai Co. LtdEncysive Pharmaceuticals IncH. Lundbeck A/SSankyo Co LtdSanofi-SynthelaboSolvay SATakeda Chemical Industries LtdWatson Pharmaceuticals IncWyethYamanouchi Pharmaceutical Co LtdBig BiotechAmgen IncApplera CorporationBiogen Inc and IDEC PharmaceuticalsChiron CorporationGenzyme CorporationSerono SAMid-Size BiotechCelltech Group PLCElan Corporation PLCImmuno-Designed Molecules (IDM) SAJapan Tobacco IncKirin Brewery Co LtdKyowa Hakko Kogyo Co LtdSeikagaku CorporationTaisho Pharmaceutical Co LtdTranskaryotic Therapies IncZenyaku Kogyo Co LtdOthersBASFThe Dow Chemical CompanyE.I. DuPont de Nemours and CompanyMonsanto CompanyNational Institutes of HealthThe Procter & Gamble CompanySyngenta International AGWorld Drug Discovery Contract Research Markets, Market Opportunity AnalysisMarket OverviewTotal Market Opportunity AnalysisOpportunity AnalysisBig PharmaMid-size PharmaBig BiotechMid-size BiotechOthersWorld Drug Discovery Contract Research Markets, Sustainable Growth StrategiesEntry StrategiesSelecting the Right SegmentDeveloping Innovative Technology PlatformsSelecting the Right PartnerGrowth StrategiesFocus on Strong OutsourcersFocus on Therapeutic Areas Witnessing Cutting-Edge ResearchBuild a Strong ReputationWorld Drug Discovery Contract Research Markets, Database of Key Industry ParticipantsKey Industry ParticipantsList of Participants

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.